RCAG
GHDX

Rehmann Capital Advisory Group’s Genomic Health, Inc. GHDX Stock Holding History

Rehmann Capital Advisory Group’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$1.76K Hold
26
– – ﹤0.01% 1440
2019
Q2 		$1.51K Hold
26
– – ﹤0.01% 1842
2019
Q1 		$1.82K Buy
+26
New +$1.93K ﹤0.01% 1796
2018
Q3 		– Sell
-21
Closed -$1.06K – 2212
2018
Q2 		$1.06K Buy
+21
New +$833 ﹤0.01% 1954

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Rehmann Capital Advisory Group's GHDX Position: Q3 2019 in Review

Rehmann Capital Advisory Group held its Genomic Health, Inc. (GHDX) position steady in Q3 2019 at 26 shares worth $1.76K. The position accounts for ﹤0.01% of the portfolio, ranked #1440.

Rehmann Capital Advisory Group first reported a position in GHDX in Q2 2018 and has held it in 4 quarters since. The position peaked at $1.82K in Q1 2019. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Rehmann Capital Advisory Group held 26 shares of Genomic Health, Inc. worth $1.76K as of Q3 2019.
  • Rehmann Capital Advisory Group left its Genomic Health, Inc. share count unchanged in Q3 2019.
  • Genomic Health, Inc. made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #1440 holding.
  • Rehmann Capital Advisory Group first reported a position in Genomic Health, Inc. in Q2 2018 and has held it in 4 quarters since.
  • Rehmann Capital Advisory Group's Genomic Health, Inc. position peaked at $1.82K in Q1 2019.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.